Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01007994 · ClinicalTrials.gov registry record · Phase 2
Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients
A Phase 2 study of Hypertension Secondary to Kidney Transplant, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
- 2
- Study locations
NCT01007994 is a Phase 2 study of Hypertension Secondary to Kidney Transplant that has completed, run by Northwell Health. The registered enrollment target is 33 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT01007994, a Phase 2 study of Hypertension Secondary to Kidney Transplant, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed study investigated the effect of chronotherapeutic alteration of anti-hypertensive medication on nocturnal hypertension and end-organ injury in pediatric renal transplant recipients who are non-dippers. Additionally, the investigators examined the association between response to intervention, serum adiponectin levels and adiponectin gene polymorphisms. The investigators hypothesized that (1) evening administration of anti-hypertensive medication will convert subjects from non-dipper to dipper status, improve mean nocturnal blood pressure (BP), and improve nocturnal BP load, (2) evening administration of anti-hypertensive medication will reduce albuminuria, left ventricular mass index (LVMI), rate of decline of glomerular filtration rate (eGFR) and will decrease pulse wave velocity (PWV).
Conditions Studied
Interventions
- DRUG New Medication: Enalapril, Isradipine, Propranolol
Study Locations (2)
New York
- Cohen Children's Medical Center of NY - New Hyde Park
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2009-11 |
| Est. Completion | 2020-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01007994
The ClinicalTrials.gov registry entry for NCT01007994 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension Secondary to Kidney Transplant appearing as the primary indexed condition, and to 1 intervention - of which New Medication: Enalapril, Isradipine, Propranolol is the first listed.
NCT01007994 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01007994 about?
NCT01007994 is a clinical study titled "Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients". The proposed study investigated the effect of chronotherapeutic alteration of anti-hypertensive medication on nocturnal hypertension and end-organ injury in pediatric renal transplant recipients who are non-dippers. Additionally, the investigators examined the association between response to interve...
What is the current status of trial NCT01007994?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2009-11. Estimated completion is 2020-08.
What conditions does trial NCT01007994 study?
This clinical trial studies the following conditions: Hypertension Secondary to Kidney Transplant.
What interventions are being tested in trial NCT01007994?
The interventions under investigation include: New Medication: Enalapril, Isradipine, Propranolol (DRUG).
Who is sponsoring clinical trial NCT01007994?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01007994 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.